Sertraline and escitalopram are widely considered the safest antidepressants for older adults. Both belong to the SSRI class, which is the standard first-line treatment for late-life depression due to once-daily dosing, relatively few drug interactions, and a favorable side effect profile compared to older antidepressant classes. That said, “safest” depends on the individual: what other medications someone takes, whether they’re at risk of falls, and whether they’re dealing with insomnia or weight loss all influence which specific drug makes the most sense.
Why SSRIs Are the First Choice
SSRIs are preferred for older adults because they cause minimal anticholinergic effects, the category of side effects most dangerous in aging brains. Anticholinergic drugs can trigger confusion, blurred vision, urinary retention, constipation, and worsened cognitive function. Older tricyclic antidepressants (like amitriptyline and nortriptyline) are notorious for these effects, which is why they’ve largely fallen out of favor for geriatric patients.
Within the SSRI class, sertraline and escitalopram stand out because they have the least potential for drug interactions. This matters enormously for older adults, who often take multiple medications for blood pressure, cholesterol, pain, or heart conditions. Other SSRIs, particularly fluoxetine and paroxetine, are more likely to interfere with how the liver processes other drugs. Paroxetine also carries notable anticholinergic effects of its own, making it the one SSRI generally avoided in elderly patients.
How Sertraline and Escitalopram Compare
At standard doses, sertraline and escitalopram perform similarly in terms of both effectiveness and side effects. About 36 to 39% of older adults taking either medication reported at least one fall in the year after starting treatment, and roughly one in five experienced recurrent falls. At low and moderate doses, there was no statistically significant difference in fall risk between the two.
At higher doses, the picture shifts slightly. Older adults taking higher doses of citalopram or escitalopram had a greater risk of recurrent falls compared to those on higher doses of sertraline. After adjusting for other health factors, high-dose sertraline users had about 37% lower risk of repeated falls than high-dose citalopram or escitalopram users. This suggests sertraline may hold a modest safety advantage when higher doses are needed to control symptoms.
Citalopram, the close chemical cousin of escitalopram, has an additional cardiac concern. The FDA capped its maximum recommended dose at 20 mg per day for anyone over 60 because higher doses can cause abnormal heart rhythms by prolonging a specific electrical interval in the heart. Escitalopram doesn’t carry the same restriction as strongly, but the concern is worth noting if cardiac health is a factor.
When a Different Antidepressant Makes More Sense
If an SSRI doesn’t work well enough or causes intolerable side effects, several alternatives are considered safe second-line options for older adults. These include SNRIs (like duloxetine and venlafaxine), bupropion, mirtazapine, and vortioxetine. All have minimal anticholinergic effects.
Mirtazapine occupies a useful niche. It blocks histamine receptors in the brain, which promotes sleep and increases appetite. For older adults struggling with insomnia or unintentional weight loss alongside depression, mirtazapine can address multiple problems at once. A randomized trial in older adults (the MIRAGE study) confirmed it reduces chronic insomnia symptoms. The sedation that makes it a poor fit for some younger patients can be genuinely helpful for an elderly person who isn’t sleeping.
Bupropion works through a different mechanism than SSRIs and doesn’t carry the same risks of low sodium or sexual side effects. It can be a good option for older adults who are sensitive to those particular problems, though it’s generally avoided in people with a seizure history.
Side Effects That Matter Most in Older Adults
Falls are the single biggest safety concern with any antidepressant in this age group. SSRIs can cause dizziness, lightheadedness, and unsteadiness, particularly in the first few weeks. Since falls in older adults can lead to hip fractures and hospitalizations, this risk shapes prescribing decisions more than almost any other factor.
Low sodium (hyponatremia) is another SSRI-specific risk that hits older adults harder. SSRIs can cause the body to hold onto too much water, diluting sodium levels in the blood. About 9% of older adults on SSRIs develop low sodium levels. That number climbs to around 13% for those also taking thiazide diuretics, a common blood pressure medication. Symptoms include confusion, headache, nausea, and in severe cases, seizures. Sodium levels are typically checked within the first few weeks of starting an SSRI.
Bleeding risk is the third concern worth understanding. SSRIs affect how platelets work, which can increase the chance of gastrointestinal bleeding. This risk multiplies when SSRIs are combined with common medications older adults frequently use: NSAIDs like ibuprofen or diclofenac, blood thinners like warfarin or apixaban, or antiplatelet drugs like aspirin. One retrospective study found that the combination of escitalopram and the blood thinner enoxaparin increased the risk of major bleeding nearly 19-fold. If you’re taking a blood thinner or use NSAIDs regularly, this interaction needs to be part of the conversation about which antidepressant to choose.
Dosing for Older Adults
The standard approach is “start low, go slow, but don’t stop.” Starting doses for older adults are typically one-quarter to one-half of what a younger adult would take. For escitalopram, that means beginning at 2.5 mg rather than the usual 10 mg starting dose. The dose is then gradually increased, giving the body time to adjust and making side effects easier to catch early.
The “don’t stop” part is important. Older adults sometimes stay on subtherapeutic doses because of a cautious instinct to keep the dose as low as possible. But a dose that’s too low to be effective isn’t actually safer; it just means the person is experiencing side effects without getting any benefit. Gradual upward titration until symptoms improve is the goal.
How Long It Takes to Work
There’s a long-standing belief that antidepressants take longer to work in older adults than in younger people. Research doesn’t support this. Clinical evidence shows that older patients generally respond within the same timeframe as younger adults, typically 4 to 6 weeks for a noticeable improvement, with full effects building over 8 to 12 weeks. Response rates are also comparable. The key difference isn’t that the medication works more slowly; it’s that the slower dose increases at the beginning can extend the time before someone reaches an effective dose.